Ineligibility and refusal to participate in randomised trials of treatments for drug dependence

Drug and Alcohol Review

Volumn 29, Issue 2, 2010, Pages 193-201

  Melberg, Hans O ^a   Humphreys, Keith ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Eligibility criteria; Randomisation; Selection bias

Indexed keywords

ADDICTION; EPIDEMIOLOGY; HUMAN; METHODOLOGY; PATIENT SELECTION; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RESEARCH SUBJECT; REVIEW; SAMPLE SIZE; STANDARD; TREATMENT REFUSAL;

HUMANS; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH SUBJECTS; SAMPLE SIZE; SELECTION BIAS; SUBSTANCE-RELATED DISORDERS; TREATMENT REFUSAL;

EID: 77953879882     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2009.00096.x     Document Type: Review

References (64)

1. Gerstein DR, Johnson RA. Nonresponse and selection bias in treatment follow-up studies. Subst Use Misuse 2000, 35:971-1014.
2. Barer D. Patients' preferences and randomised trials. Lancet 1994, 344:688.
3. Dehue TA. Dutch treat: randomized controlled experimentation and the case of heroin-maintenance in the Netherlands. Hist Hum Sci 2002, 15:75-98.
4. Finch E, Gossop M, Hankinson L, Taylor C, Farrell M, Strang J. Patients' preferences and randomised trials. Lancet 1994, 344:688-9.
5. Ashery RS, McAuliffe WE. Implementation issues and techniques in randomized trials of outpatient psychosocial treatments for drug abusers: recruitment of subjects. Am J Drug Alcohol Abuse 1992, 18:305-29.
6. Berglund M, Thelander S, Jonsson E. Treating alcohol and drug abuse: an evidence based review 2003, Weinheim, Cambridge, John Wiley & Sons, Ltd
7. Lingford-Hughes AR, Welch S, Nutt DJ. Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for psychopharmacology. J Psychopharmacol 2004, 18:293-335.
8. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials: N Engl J Med. 2000, 1878-86.
9. Britton A, McKee M, Black N, McPherson K, Sanderson C, Bain C. Choosing between randomised and non-randomised studies: a systematic review. Health Technol Assess 1998, 2:1-124.
10. McKay JR, Alterman AI, McLellan AT, Boardman CR, Mulvaney FD, O'Brien CP. Random versus nonrandom assignment in the evaluation of treatment for cocaine abusers. J Consult Clin Psychol 1998, 66:697-701.
11. Smith GC, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ 2003, 327:1459-61.
12. Humphreys K, Weisner C. Use of exclusion criteria in selecting research subjects and its effect on the generalizability of alcohol treatment outcome studies. Am J Psychiatry 2000, 154:588-94.
13. Cornish JW, Metzger D, Woody GE. Naltrexone pharmacotherapy for opioid dependent federal probationers. J Subst Abuse Treat 1997, 14:529-34.
14. Covi L, Hess JM, Kreiter NA, Haertzen CA. Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers. Am J Drug Alcohol Abuse 1995, 21:327-44.
15. Houston CC, Milby JB. Drug-seeking behavior and its mediation: effects of aversion therapy with narcotic addicts on methadone. Int J Addict 1983, 18:1171-7.
16. Weddington WW, Brown BS, Haertzen CA. Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. Am J Drug Alcohol Abuse 1991, 17:137-52.
17. Handelsman L, Limpitlaw L, Williams D, Schmeidler J, Paris P, Stimmel B. Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients. Drug Alcohol Depend 1995, 39:173-80.
18. Bearn J, Gossop M, Strang J. Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal. Drug Alcohol Depend 1996, 43:87-91.
19. Dawe S, Powell J, Richards D. Does post-withdrawal cue exposure improve outcome in opiate addiction? A controlled trial. Addiction 1993, 88:1233-45.
20. Gossop M, Johns A, Green L. Opiate withdrawal: inpatient versus outpatient programmes and preferred versus random assignment to treatment. Br Med J 1986, 293:103-4.
21. Carnwath T, Hardman J. Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal. Drug Alcohol Depend 1998, 50:251-4.
22. Umbricht A, Montoya ID, Hoover DR, Demuth KL, Chiang CT, Preston KL. Naltrexone shortened opioid detoxification with buprenorphine. Drug Alcohol Depend 1999, 56:181-90.
23. Burnam MA, Morton SC, McGlynn EA. An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. J Addict Dis 1995, 14:111-34.
24. McKay JR, McLellan AT, Alterman AI, Cacciola JS, Rutherford MJ, O'Brien CP. Predictors of participation in aftercare sessions and self-help groups following completion of intensive outpatient treatment for substance abuse. J Stud Alcohol 1998, 59:152-62.
25. Sosin MR, Bruni M, Reidy M. Paths and impacts in the progressive independence model: a homelessness and substance abuse intervention in Chicago. J Addict Dis 1995, 14:1-20.
26. Cornish JW, Maany I, Fudala PJ. Carbamazepine treatment for cocaine dependence. Drug Alcohol Depend 1995, 38:221-7.
27. Kranzler HR, Bauer LO, Hersh D, Klinghoffer V. Carbamazepine treatment of cocaine dependence: a placebo-controlled trial. Drug Alcohol Depend 1995, 38:203-11.
28. Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Methadone dose and treatment outcome. Drug Alcohol Depend 1993, 33:105-17.
29. Saunders B, Wilkinson C, Phillips M. The impact of a brief motivational intervention with opiate users attending a methadone programme. Addiction 1995, 90:415-24.
30. Handelsman L, Rosenblum A, Palij M. Bromocriptine for cocaine dependence. A controlled clinical trial. Am J Addict 1997, 6:54-64.
31. Catalano RF, Haggerty KP, Gainey RR, Hoppe MJ. Reducing parental risk factors for children's substance misuse: preliminary outcomes with opiate-addicted parents. Subst Use Misuse 1997, 32:699-721.
32. Svikis DS, Lee JH, Haug NA, Stitzer ML. Attendance incentives for outpatient treatment: effects in methadone- and nonmethadone-maintained pregnant drug dependent women. Drug Alcohol Depend 1997, 48:33-41.
33. Schmitz JM, Oswald LM, Jacks SD, Rustin T, Rhoades HM, Grabowski J. Relapse prevention treatment for cocaine dependence: group vs. individual format. Addict Behav 1997, 22:405-18.
34. Montoya ID, Levin FR, Fudala PJ, Gorelick DA. Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence. Drug Alcohol Depend 1995, 38:213-19.
35. Bowman V, Ward LC, Bowman D, Scogin F. Self-examination therapy as an adjunct treatment for depressive symptoms in substance abusing patients. Addict Behav 1996, 21:129-33.
36. McCusker J, Bigelow C, Vickers-Lahti M, Spotts D, Garfield F, Frost R. Planned duration of residential drug abuse treatment: efficacy versus effectiveness. Addiction 1997, 92:1467-78.
37. San L, Cami J, Fernandez T, Olle JM, Peri JM, Torrens M. Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects. Br J Addict 1992, 87:55-62.
38. Kidorf M, Stitzer ML, Brooner RK, Goldberg J. Contingent methadone take-home doses reinforce adjunct therapy attendance of methadone maintenance patients. Drug Alcohol Depend 1994, 36:221-6.
39. Brooner RK, Kidorf M, King VL, Stoller K. Preliminary evidence of good treatment response in antisocial drug abusers. Drug Alcohol Depend 1998, 49:249-60.
40. Vickers-Lahti M, Garfield F, McCusker J. The relationship between legal factors and attrition from a residential drug abuse treatment program. J Psychoactive Drugs 1995, 27:17-25.
41. Carroll KM, Nich C, Ball SA, McCance E, Rounsavile BJ. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction 1998, 93:713-27.
42. Abbott PJ, Weller SB, Delaney HD, Moore BA. Community reinforcement approach in the treatment of opiate addicts. Am J Drug Alcohol Abuse 1998, 24:17-30.
43. San L, Fernandez T, Cami J, Gossop M. Efficacy of methadone versus methadone and guanfacine in the detoxification of heroin-addicted patients. J Subst Abuse Treat 1994, 11:463-9.
44. Calsyn DA, Wells EA, Saxon AJ. Contingency management of urinalysis results and intensity of counseling services have an interactive impact on methadone maintenance treatment outcome. J Addict Dis 1994, 13:47-63.
45. Preston KL, Silverman K, Umbricht A, DeJesus A, Montoya ID, Schuster CR. Improvement in naltrexone treatment compliance with contingency management. Drug Alcohol Depend 1999, 54:127-35.
46. Nunes EV, McGrath PJ, Quitkin FM. Imipramine treatment of cocaine abuse: possible boundaries of efficacy. Drug Alcohol Depend 1995, 39:185-95.
47. Leal J, Ziedonis D, Kosten T. Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence. Drug Alcohol Depend 1994, 35:31-5.
48. Kolar AF, Brown BS, Weddington WW, Haertzen CC, Michaelson BS, Jaffe JH. Treatment of cocaine dependence in methadone maintenance clients: a pilot study comparing the efficacy of desipramine and amantadine. Int J Addict 1992, 27:849-68.
49. Landabaso MA, Iraurgi I, Jimenez-Lerma JM. A randomized trial of adding fluoxetine to a naltrexone treatment programme for heroin addicts. Addiction 1998, 93:739-44.
50. Higgins ST, Stitzer ML, Bigelow GE, Liebson IA. Contingent methadone delivery: effects on illicit-opiate use. Drug Alcohol Depend 1986, 17:311-22.
51. Drummond DC, Turkington D, Rahman MZ, Mullin PJ, Jackson P. Chlordiazepoxide vs. methadone in opiate withdrawal: a preliminary double blind trial. Drug Alcohol Depend 1989, 23:63-71.
52. Smith EM, North CS, Fox LW. Eighteen-month follow-up data on a treatment program for homeless substance abusing mothers. J Addict Dis 1995, 14:57-72.
53. Iguchi MY, Stitzer ML, Bigelow GE, Liebson IA. Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use. Drug Alcohol Depend 1988, 22:1-7.
54. Hiller ML, Rowan-Szal GA, Bartholomew NG, Simpson DD. Effectiveness of a specialized women's intervention in a residential treatment program. Subst Use Misuse 1996, 31:771-83.
55. Elk R, Mangus L, Rhoades H, Andres R, Grabowski J. Cessation of cocaine use during pregnancy: effects of contingency management interventions on maintaining abstinence and complying with prenatal care. Addict Behav 1998, 23:57-64.
56. Dansereau DF, Joe GW, Simpson DD. Attentional difficulties and the effectiveness of a visual representation strategy for counseling drug-addicted clients. Int J Addict 1995, 30:371-86.
57. Braucht GN, Reichardt CS, Geissler LJ, Bormann CA, Kwiatkowski CF, Kirby MW. Effective services for homeless substance abusers. J Addict Dis 1995, 14:87-109.
58. Galloway GP, Newmeyer J, Knapp T, Stalcup SA, Smith D. Imipramine for the treatment of cocaine and methamphetamine dependence. J Addict Dis 1994, 13:201-16.
59. Alterman AI, Droba M, Antelo RE. Amantadine may facilitate detoxification of cocaine addicts. Drug Alcohol Depend 1992, 31:19-29.
60. Velasquez MM, DiClemente CC, Addy RC. Generalizability of project MATCH: a comparison of clients enrolled to those not enrolled in the study at one aftercare site. Drug Alcohol Depend 2000, 59:177-82.
61. Humphreys K, Harris AHS, Weingardt KR. Subject eligibility criteria can substantially influence the results of alcohol-treatment outcome research. J Stud Alcohol 2008, 69:757-64.
62. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. J Stud Alcohol 1998, 59:631-9. Project MATCH RG
63. Sosin MR. Outcomes and sample selection: the case of a homelessness and substance abuse intervention. Br J Math Stat Psychol 2002, 55:63-91.
64. Winship C, Mare RD. Models for sample selection bias. Annu Rev Sociol 1992, 18:327-50.